Running a head-to-head comparison... reveals mechanism-specific effects
Running a head-to-head comparison... reveals mechanism-specific effects
Roles and dose notes are as recorded from the source below — each member’s own page holds its sourced dosing and evidence (the same rows the peptide pages render).
Single-receptor GLP-1 agonist
Semaglutide is a special medicine used by doctors to help people with two main health problems. It is used by adults with type 2 diabetes to keep their blood sugar levels normal.
As recorded in this stack’s source: Matched purity standards
Dual-receptor GLP-1/GIP agonist
Tirzepatide is a medicine used by doctors to help people with type 2 diabetes and people who need to lose weight. It is a man-made compound that acts like two different natural hormones in the body at the same time.
As recorded in this stack’s source: Matched purity standards
Triple-receptor GLP-1/GIP/Glucagon agonist
Retatrutide is a new type of medicine being studied for health problems. It is a peptide, which is a small chain of amino acids.
As recorded in this stack’s source: Matched purity standards
["Validates research across the agonist spectrum","Reveals mechanism-specific effects"]
Extracted from a vendor source — see the original page ↗. Stacks like this are community- and vendor-reported combinations, not clinically established protocols. For research purposes only — not medical advice.
The most-used peptide combinations, what the research actually says, and where to buy — one page, one email.
No spam. Unsubscribe anytime.